Nixon Peabody Trust’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q2 | – | Sell |
-7,186
| Closed | -$1.7M | – | 80 |
|
2019
Q1 | $1.7M | Buy |
7,186
+637
| +10% | +$151K | 1.11% | 40 |
|
2018
Q4 | $1.97M | Buy |
6,549
+41
| +0.6% | +$12.3K | 1.55% | 30 |
|
2018
Q3 | $2.3M | Sell |
6,508
-253
| -4% | -$89.4K | 1.57% | 32 |
|
2018
Q2 | $1.96M | Buy |
6,761
+240
| +4% | +$69.6K | 1.52% | 31 |
|
2018
Q1 | $1.79M | Buy |
6,521
+157
| +2% | +$43K | 1.6% | 32 |
|
2017
Q4 | $2.03M | Buy |
6,364
+130
| +2% | +$41.4K | 1.75% | 31 |
|
2017
Q3 | $1.95M | Buy |
6,234
+55
| +0.9% | +$17.2K | 1.77% | 29 |
|
2017
Q2 | $1.68M | Buy |
6,179
+120
| +2% | +$32.6K | 1.55% | 32 |
|
2017
Q1 | $1.66M | Buy |
6,059
+115
| +2% | +$31.5K | 1.56% | 34 |
|
2016
Q4 | $1.69M | Buy |
5,944
+485
| +9% | +$138K | 1.64% | 30 |
|
2016
Q3 | $1.71M | Buy |
5,459
+46
| +0.8% | +$14.4K | 1.68% | 27 |
|
2016
Q2 | $1.31M | Buy |
+5,413
| New | +$1.31M | 1.14% | 38 |
|